2 Followers on Owler
OverviewCompetitorsNews & Insights

VIBATIV Competitors or Alternatives

VIBATIV's top competitors include Spero Therapeutics, Achaogen and Aridis.

Unlock 24 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

VIBATIV's company profile

CEO

- -
$0
$100K - 5M
  • $0
    $100K - 5M
  • $0
  • $100K - 5M
  • - -
  • $0
  • $100K - 5M
View ProfileView
1
VIBATIV's Competitor - Spero Therapeutics logo

Sath Shukla

President & CEO

82/100
150
$463.8M
$48M
  • $463.8M
    $48M
  • 150
    $463.8M
  • $48M
  • 82/100
  • 150
  • $463.8M
  • $48M
View ProfileView
2
VIBATIV's Competitor - Achaogen logo

Blake Wise

CEO

77/100
1 - 25
$221.4M
$100K - 5M
  • $221.4M
    $100K - 5M
  • 1 - 25
    $221.4M
  • $100K - 5M
  • 77/100
  • 1 - 25
  • $221.4M
  • $100K - 5M
View ProfileView
3
VIBATIV's Competitor - Aridis logo

Vu L. Truong

Founder & CEO

91/100
30
$121.7M
$22.4M
  • $121.7M
    $22.4M
  • 30
    $121.7M
  • $22.4M
  • 91/100
  • 30
  • $121.7M
  • $22.4M
View ProfileView
4
VIBATIV's Competitor - Forge Therapeutics logo

Zachary Zimmerman

Co-Founder & CEO

87/100
25 - 100
$15M
$100K - 5M
  • $15M
    $100K - 5M
  • 25 - 100
    $15M
  • $100K - 5M
  • 87/100
  • 25 - 100
  • $15M
  • $100K - 5M
View ProfileView
5
VIBATIV's Competitor - Melinta logo

Christine Ann Miller

President & CEO

88/100
250 - 500
$558.3M
$25M - 100M
  • $558.3M
    $25M - 100M
  • 250 - 500
    $558.3M
  • $25M - 100M
  • 88/100
  • 250 - 500
  • $558.3M
  • $25M - 100M
View ProfileView
VIBATIV's top 27 competitors are Spero Therapeutics, Achaogen, Aridis, Pear, Forge Therapeutics, Melinta, Tetraphase, Adimab, Vir, Cipla, Adenium Biotech, Merck, Alopexx, UTILITY Therapeutics, AstraZeneca, Entasis, Hookipa Pharma, Interchem Corporation, VBI, Inovio, Olon, BioCryst, PaxVax, Dynavax, Kite Pharma, American Antibiotics and bluebird bio. Together they have raised over 16.3B between their estimated 207.7K employees. VIBATIV's revenue is the ranked 23th among it's top 10 competitors. The top 10 competitors average 4.6B.

VIBATIV VS Spero Therapeutics

Spero Therapeutics is one of VIBATIV's top competitors. Spero Therapeutics was founded in 2013, and its headquarters is in Cambridge, Massachusetts. Like VIBATIV, Spero Therapeutics also works within the Biotechnology sector. Spero Therapeutics has 150 more employees than VIBATIV.

VIBATIV VS Achaogen

Achaogen is VIBATIV's #2 rival. Achaogen was founded in 2004 in South San Francisco, California. Achaogen operates in the Biotechnology industry. Achaogen generates $1.1M more revenue than VIBATIV.

VIBATIV VS Aridis

Aridis is a top competitor of VIBATIV. Aridis is a Public company that was founded in Los Gatos, California in 2003. Aridis is in the Pharmaceuticals field. Aridis has 30 more employees vs. VIBATIV.

Looking for similar companies to VIBATIV?

Similar Companies

Biotechnology companies in San Francisco

See 326 companies 
Biotechnology companies in San Francisco Bay Area

See 1,319 companies 
Pharmaceuticals & Biotechnology companies in San Francisco

See 386 companies 
Pharmaceuticals & Biotechnology companies in San Francisco Bay Area

See 1,673 companies 
Biotechnology companies in California

See 3,097 companies 
Pharmaceuticals & Biotechnology companies in California

See 4,181 companies 
Biotechnology companies in USA

See 11,803 companies 
Biotechnology companies in North America

See 13,207 companies 
Pharmaceuticals & Biotechnology companies in USA

See 18,348 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for VIBATIV and VIBATIV's Competitors

April 12, 2025Benzinga
NEW YORK, April 12, 2025 (GLOBE NEWSWIRE) --WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Merck & Co., In...
April 12, 2025Indian Pharma Post
Protein-bound Paclitaxel is indicated for the treatment of metastatic breast cancer, locally advanced or metastatic non-small cell lung cancer and meta...
April 11, 2025FinanzNachrichten
LONDON (dpa-AFX) - AstraZeneca PLC (AZN.L) Friday announced that all resolutions at its Annual General Meeting were approved by shareholders, with over...
April 11, 2025Marketscreener
The Law Offices of Frank R. Cruz reminds investors of the upcoming April 14, 2025 deadline to participate as a lead plaintiff in the securities fraud c...
April 11, 2025The Hindu Business Line
Cipla receives USFDA approval for paclitaxel protein-bound particles for injectable suspension (albumin-bound), 100 mg/vial, single-dose vial...
April 11, 2025Pharamceutical Technology
The twice daily tablet represents a significant step forward for patients with advanced breast cancer....
April 11, 2025Business Standard
Cipla said USFDA has approved the ANDA submitted for Paclitaxel Protein-bound Particles for Injectable Suspension (albumin-bound), 100 mg/vial, Single-...
April 11, 2025Openpr
Neuroregeneration Therapy Market is estimated to be valued at USD 14.77 Bn in 2025 and is expected to reach USD 33.69 Bn in 2032, exhibiting a compound...

Frequently Asked Questions about VIBATIV

  1. Who are VIBATIV's top competitors?

    VIBATIV's top 3 competitors are Spero Therapeutics, Achaogen, Aridis.

  2. Who is similar to VIBATIV?

    Spero Therapeutics is the most similar to VIBATIV. Achaogen and Aridis are also similar to VIBATIV.

  1. Are VIBATIV and Spero Therapeutics competitors?

    Yes, Spero Therapeutics is one of VIBATIV’s top competitors.